Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Zolmitriptan manufacturers

8 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

8 products found

zolmitriptan

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Canada
Manufacturer #17753
This company is a global pharmaceutical manufacturer with decades of experience in the industry. They specialize in developing and manufacturing generic versions of complex and niche pharmaceutical products, with a focus on affordability and accessibility. Key areas of expertise include oncology, where they have achieved notable success in launching generic versions of blockbuster drugs. They also have a strong presence in the production of Rx products, OTC products, and APIs. Their product portfolio includes various dosage forms, including solids, injectables, and orals, all produced in facilities with EU and US GMP approvals. Their commitment to innovation and quality has led to the development of a robust R&D pipeline and a strong track record of successful product launches in key regions such as North America and the EU.

Manufacturer usually replies in 2 days

zolmitriptan

Tablets 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Czech Republic , Germany , Netherlands , Poland , Romania , Slovakia , Spain , United Kingdom
Comments
DCP approved
Manufacturer #6978
This global pharmaceutical company specializes in branded and generic medications, offering a wide range of products across various therapeutic areas including dermatology, oncology, and respiratory therapy. They prioritize quality manufacturing with GMP certifications and hold several patents for their innovative drug formulations. The company boasts a strong global presence spanning North America, Europe, Asia, Africa, Latin America, and the Middle East, with multiple manufacturing facilities strategically located in key regions. Their commitment to research and development is evident through dedicated R&D centers focused on advancing therapies and improving patient care worldwide.

Manufacturer usually replies in 48 days

zolmitriptan

Tablets, orally disintegrating (ODT) 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Czech Republic , Germany , Mexico , Netherlands , Poland , Romania , Slovakia , Spain , United Arab Emirates , United Kingdom
Comments
DCP approved
Manufacturer #6978
This global pharmaceutical company specializes in branded and generic medications, offering a wide range of products across various therapeutic areas including dermatology, oncology, and respiratory therapy. They prioritize quality manufacturing with GMP certifications and hold several patents for their innovative drug formulations. The company boasts a strong global presence spanning North America, Europe, Asia, Africa, Latin America, and the Middle East, with multiple manufacturing facilities strategically located in key regions. Their commitment to research and development is evident through dedicated R&D centers focused on advancing therapies and improving patient care worldwide.

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Zolmitriptan is a medication used to treat severe migraines. Suppliers of zolmitriptan market it in the form of 2.5mg and 5mg tablets, as well as nasal sprays. Alternatives to zolmitriptan are other triptan class medications, namely, sumatriptan, naratriptan, rizatriptan, almotriptan, eletriptan, and frovatriptan. The drug was first introduced into the pharmaceutical market in 1997 and has since then become approved in over 100 countries globally, including but not limited to geographical markets China, Australia, Japan, Brazil, as well as across Europe. The largest manufacturers and suppliers of zolmitriptan medications are companies Sun Pharmaceuticals, Teva, and AstraZeneca. Following patent expiry in 2013, other manufacturers launched their generic formulations of zolmitriptan. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified zolmitriptan manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Retail prices for 6 (2.5mg) tablets of zolmitriptan are approximately 30 EUR to 40 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible